• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性系统性硬化症中真皮肥大细胞数量增加:慢性纤维化的一个关联?

Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?

作者信息

Hawkins R A, Claman H N, Clark R A, Steigerwald J C

出版信息

Ann Intern Med. 1985 Feb;102(2):182-6. doi: 10.7326/0003-4819-102-2-182.

DOI:10.7326/0003-4819-102-2-182
PMID:3966756
Abstract

Dermal collagen deposition is the hallmark of the early indurative phase of progressive systemic sclerosis (scleroderma). This process, however, tends to remit in late stages of the disease. Because mast cells are believed to participate in the development of fibrotic processes, we measured the density of the cutaneous mast cell population in clinically involved and uninvolved skin of a group of patients with scleroderma. Mast cell counts in clinically involved skin of patients with early stages of scleroderma (111 +/- 28 [SD] cells/mm2) were significantly greater than those in clinically uninvolved skin of the same patients (58 +/- 26 cells/mm2) and also greater than those of normal controls (50 +/- 14 cells/mm2). Mast cell counts in clinically involved and uninvolved skin of patients with late scleroderma were normal. When mast cell density was analyzed by depth of dermis, an 85% increase was noted in involved papillary dermis and a 152% increase in involved reticular dermis in patients with early scleroderma when compared with densities in controls. These results suggest that mast cells may be important in the pathogenesis of the early cutaneous lesions of progressive systemic sclerosis, perhaps by promoting fibrosis.

摘要

真皮胶原沉积是进行性系统性硬化症(硬皮病)早期硬结阶段的标志。然而,这一过程在疾病后期往往会缓解。由于肥大细胞被认为参与纤维化过程的发展,我们测量了一组硬皮病患者临床受累皮肤和未受累皮肤中皮肤肥大细胞群体的密度。硬皮病早期患者临床受累皮肤中的肥大细胞计数(111±28[标准差]个细胞/mm²)显著高于同一患者临床未受累皮肤中的计数(58±26个细胞/mm²),也高于正常对照组(50±14个细胞/mm²)。晚期硬皮病患者临床受累和未受累皮肤中的肥大细胞计数正常。当按真皮深度分析肥大细胞密度时,与对照组密度相比,早期硬皮病患者受累乳头层真皮中肥大细胞密度增加85%,受累网状层真皮中增加152%。这些结果表明,肥大细胞可能在进行性系统性硬化症早期皮肤病变的发病机制中起重要作用,可能是通过促进纤维化。

相似文献

1
Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?进行性系统性硬化症中真皮肥大细胞数量增加:慢性纤维化的一个关联?
Ann Intern Med. 1985 Feb;102(2):182-6. doi: 10.7326/0003-4819-102-2-182.
2
Mast cell numbers in diffuse scleroderma.弥漫性硬皮病中的肥大细胞数量
Arch Dermatol. 1987 Feb;123(2):205-8.
3
Dermal mast cell degranulation in systemic sclerosis.系统性硬化症中的皮肤肥大细胞脱颗粒
Arthritis Rheum. 1990 Nov;33(11):1702-9. doi: 10.1002/art.1780331114.
4
Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis.手指皮肤中的肥大细胞密度反映了系统性硬皮病皮肤硬化的严重程度。
Mod Rheumatol. 2013 Nov;23(6):1151-7. doi: 10.1007/s10165-012-0813-8. Epub 2012 Dec 28.
5
Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.硬皮病中的皮肤肥大细胞:其皮肤密度、类胰蛋白酶/糜蛋白酶表型及脱颗粒情况。
Br J Dermatol. 1998 Mar;138(3):399-406. doi: 10.1046/j.1365-2133.1998.02114.x.
6
Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.硬皮病中的肥大细胞变化。皮肤中MCT细胞的存在及肥大细胞活化的证据。
Arthritis Rheum. 1992 Aug;35(8):933-9. doi: 10.1002/art.1780350813.
7
Increased mast cell numbers in the sclerotic skin of porphyria cutanea tarda.迟发性皮肤卟啉病硬化皮肤中肥大细胞数量增加。
Dermatologica. 1989;178(2):75-8. doi: 10.1159/000248396.
8
Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.硬化皮肤的动物模型。II. 博来霉素诱导遗传性肥大细胞缺陷的WBB6F1-W/W(V)小鼠发生硬皮病。
J Rheumatol. 1999 Dec;26(12):2628-34.
9
Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermis.硬皮病中的免疫功能障碍:真皮中肥大细胞释放能力增强及HLA - DR阳性的证据。
Arthritis Rheum. 1988 May;31(5):672-7. doi: 10.1002/art.1780310514.
10
Expression of stem cell factor in the lesional skin of systemic sclerosis.干细胞因子在系统性硬化症皮损中的表达。
Dermatology. 1998;197(2):109-14. doi: 10.1159/000017979.

引用本文的文献

1
Genetic and molecular drivers of scleroderma pathogenesis.硬皮病发病机制的遗传和分子驱动因素。
Clin Dermatol. 2025 Mar-Apr;43(2):153-159. doi: 10.1016/j.clindermatol.2024.12.007. Epub 2024 Dec 13.
2
Detection of Mast Cells in Human Superficial Fascia.人浅筋膜中肥大细胞的检测。
Int J Mol Sci. 2023 Jul 18;24(14):11599. doi: 10.3390/ijms241411599.
3
Roles of Mast Cells in Cutaneous Diseases.肥大细胞在皮肤疾病中的作用。
Front Immunol. 2022 Jul 6;13:923495. doi: 10.3389/fimmu.2022.923495. eCollection 2022.
4
Connecting the Dots in Emerging Mast Cell Research: Do Factors Affecting Mast Cell Activation Provide a Missing Link between Adverse COVID-19 Outcomes and the Social Determinants of Health?新兴肥大细胞研究中的关联:影响肥大细胞活化的因素是否为 COVID-19 不良结局与健康社会决定因素之间提供了缺失的一环?
Med Sci (Basel). 2022 May 28;10(2):29. doi: 10.3390/medsci10020029.
5
Mast Cell Activation in the Systemic Sclerosis Esophagus.系统性硬化症食管中的肥大细胞活化
J Scleroderma Relat Disord. 2021 Feb;6(1):77-86. doi: 10.1177/2397198320941322. Epub 2020 Jul 27.
6
A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis.关于肥大细胞在皮肤瘢痕和纤维化中作用的证据的综述。
Int J Mol Sci. 2020 Dec 18;21(24):9673. doi: 10.3390/ijms21249673.
7
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression.硬皮病皮肤炎症细胞浸润的特征:B 细胞与皮肤评分进展。
Arthritis Res Ther. 2018 Apr 18;20(1):75. doi: 10.1186/s13075-018-1569-0.
8
Are mast cells implicated in asphyxia?肥大细胞与窒息有关吗?
Int J Legal Med. 2016 Jan;130(1):153-61. doi: 10.1007/s00414-015-1211-5. Epub 2015 Jun 11.
9
Histamine contributes to tissue remodeling via periostin expression.组胺通过骨膜蛋白的表达促进组织重塑。
J Invest Dermatol. 2014 Aug;134(8):2105-2113. doi: 10.1038/jid.2014.120. Epub 2014 Feb 27.
10
Autophagy is a key feature in the pathogenesis of systemic sclerosis.自噬是全身性硬皮病发病机制中的一个关键特征。
Rheumatol Int. 2014 Mar;34(3):435-9. doi: 10.1007/s00296-013-2827-8. Epub 2013 Aug 11.